Citius Pharmaceuticals Reports Q3 Fiscal 2026 Results

What Happened
Citius Pharmaceuticals, Inc. (CTXR) filed a Form 8-K on August 14, 2026 (Item 2.02) to announce its results of operations and financial condition for the third quarter of fiscal 2026. The company issued a press release on that date reporting the quarterly results; the press release is furnished as Exhibit 99.1 to the 8-K and is incorporated by reference.

Key Details

• Filing date: August 14, 2026 (Form 8-K, Item 2.02).
• Period covered: third quarter of fiscal 2026 (results of operations and financial condition).
• Press release: furnished as Exhibit 99.1 to the 8-K and incorporated by reference.
• Interactive data: Cover Page Interactive Data File provided in iXBRL format (Exhibit 104).

Why It Matters
Quarterly results are a primary source of information about a company’s recent revenue, expenses, and cash position, and they can influence stock price and investor decisions. This 8-K signals that Citius has released its Q3 2026 operating results; investors should read the Exhibit 99.1 press release for the specific revenue, profit/loss, and cash metrics and watch for the related periodic filings (e.g., 10-Q) for full financial statements and management discussion.